Manufacturer or GPO Program year 2025 Source: CMS Open Payments

Boehringer Ingelheim International GmbH

Germany

CMS manufacturer 100000005541

Open in the dashboard

General payments

$23,700,916

10,756 payments

Research payments

$187,782,834

116,638 payments

Ownership & investment interest

$0

None reported

Through program year 2025, Boehringer Ingelheim International GmbH reported paying $23,700,916 in general payments and $187,782,834 in research payments to U.S. physicians, teaching hospitals and other recipients.

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

14 rows
Year Kind Amount Payments
2025 General $3,340,664 1,359
2025 Research $86,218,167 85,644
2024 General $4,473,811 2,203
2024 Research $36,652,529 1,844
2023 General $4,839,869 2,649
2023 Research $7,319,208 855
2022 General $2,833,560 1,068
2022 Research $14,377,953 767
2021 General $3,128,126 861
2021 Research $13,875,865 5,809
2020 General $2,987,218 1,165
2020 Research $14,595,171 9,473
2019 General $2,097,669 1,451
2019 Research $14,743,941 12,246

Breakdown

Top recipients General payments · program year 2025
  1. Dana-Farber Cancer Institute Teaching hospital · MA $358,068 2 payments
  2. Mount Sinai Medical Center Of Florid Teaching hospital · FL $299,500 4 payments
  3. Javed Butler Advanced Heart Failure and Transplant Cardiology · Jackson, MS $139,495 21 payments
  4. Massachusetts General Hospital Teaching hospital · MA $96,083 1 payment
  5. Biykem Bozkurt Cardiovascular Disease · Houston, TX $89,135 33 payments
  6. Toby Maher Pulmonary Disease · Los Angeles, CA $86,964 43 payments
  7. University Of Virginia Medical Cente Teaching hospital · VA $83,348 1 payment
  8. Charles Wykoff Ophthalmology · Bellaire, TX $81,463 13 payments
  9. Shervin Assassi Rheumatology · Houston, TX $73,247 35 payments
  10. Roger Goldberg Retina Specialist · Walnut Creek, CA $64,843 22 payments
Top research recipients Research payments · program year 2025
  1. Covenant Metabolic Specialists-Fort Myers $3,820,772 2,178 payments
  2. Verus Clinical Research Corporation $2,785,579 1,102 payments
  3. Covenant Research $2,512,185 1,234 payments
  4. Covenant Metabolic Specialists-Sarasota $2,265,356 1,425 payments
  5. Adventhealth Research Institute-Translational Research Institute Department $2,207,852 560 payments
  6. Texas Liver Institute Ste 101 $2,150,684 900 payments
  7. Louisiana Research Center $1,492,832 467 payments
  8. Centex Studies Inc $1,212,857 256 payments
  9. Gonzalez And Aswad MDS Office $1,172,893 479 payments
  10. Entrust Clinical Research $1,145,303 301 payments
Products the payments named General payments · program year 2025
  1. Jardiance Diabetes $112,660 66% · 6 recipients
  2. Ofev Respiratory $52,146 30% · 12 recipients
  3. Spevigo Immunology $6,170 4% · 2 recipients

Each share is of this company’s general payments naming a product in 2025. A payment can name up to five products, so these amounts overlap.

Specialties paid General payments · program year 2025
  1. Gastroenterology Internal Medicine $284,267 12% · 20 practitioners
  2. Ophthalmology $259,423 11% · 17 practitioners
  3. Pulmonary Disease Internal Medicine $245,454 10% · 21 practitioners
  4. Advanced Heart Failure and Transplant Cardiology Internal Medicine $196,878 8% · 4 practitioners
  5. Rheumatology Internal Medicine $161,231 7% · 13 practitioners

The top 5 of 40 specialties; each share is of this company’s general payments to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Massachusetts $666,273 20% · 25 recipients
  2. Texas $537,852 16% · 35 recipients
  3. California $392,454 12% · 30 recipients
  4. Florida $325,911 10% · 8 recipients
  5. Virginia $153,695 5% · 9 recipients

The top 5 of 30 states; each share is of this company’s general payments in 2025 where a state was reported.

The top 25 states, free in the app

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $12,256,776 3,491 payments
  2. Grant $5,568,431 38 payments
  3. Travel and Lodging $3,130,628 1,970 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $2,619,865 3,063 payments
  5. Food and Beverage $124,604 2,193 payments
  6. Royalty or License $613 1 payment
Companies with a similar name General payments · program years 2019–2025
  1. Boehringer Ingelheim Pharmaceuticals, Inc. CT, United States $119,273,072
  2. Boehringer Ingelheim RCV GmbH & Co KG Austria $1,008,478
  3. Boehringer Ingelheim Pharma GmbH & Co.KG Germany $565,806
  4. Boehringer Ingelheim MENA (Scientific Office) FZ-LLC United Arab Emirates $190,403
  5. Boehringer Ingelheim (Phil.) Inc. Philippines $156,755
  6. Boehringer Ingelheim Singapore Pte. Ltd. Singapore $135,030
  7. Boehringer Ingelheim b.v. Netherlands $129,191
  8. Boehringer Ingelheim Do Brasil Quimica e Farmaceutical Ltda. Brazil $112,993
  9. Boehringer Ingelheim Pty Ltd Australia $91,255
  10. Boehringer Ingelheim Canada Ltd.Ltee Canada $87,239

Grouped by name only. CMS publishes no corporate ownership, so a shared name does not mean a shared parent. The largest 10 of 34.

10,756 general · 116,638 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers of drugs, devices and biologicals, and group purchasing organisations, are required to report the payments and transfers of value they make to physicians and teaching hospitals. This page shows what this company reported.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record